Regulation of Allergen-Based Medicines in Spain | Submission Timelines Reminder

May 2, 2025
|

The Spanish Agency of Medicines and Medical Devices (Agencia Española de Medicamentos y Productos Sanitarios) published on July 12, 2024, the list of notified medicinal products, which includes a total of 17,465 notifications for allergen-based products.

Have a look at the detailed list of medicinal products for human use and the associated laboratories.

Please note that products not included on this list are not eligible for the specific regulatory process established by the AEMPS to obtain marketing authorisation (MA) at reduced costs and according to the established calendar.

At ASPHALION, we offer comprehensive and personalized regulatory support tailored to meet AEMPS requirements, including:

  • Preparation of allergen-based dossiers
  • Scientific and CMC writing
  • Scientific advice
  • Regulatory strategies
  • TAC laboratory management

 

For more information, contact us at: [email protected]

 

Search News & Events

  • Filter by category

Share

Related news and events

EVENT | DIA Europe

DIA Europe 2025 will focus on sustainability, innovation and collaboration – three key pillars for shaping the future of healthcare. From the environmental impact of pharmaceuticals and of the drug development lifecycle to sustainable partnerships and sustainable healthcare systems, DIA Europe 2025 will be the prime opportunity to discuss how collaboration and innovation can support sustainability in healthcare and each stakeholder’s role in making it happen.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting